INTRODUCTION
The HIV aspartyl protease processes the gag and gag-pol polypeptide precursors into structural proteins and enzymes (see Figure 1A ) [1, 2] . This processing step is required for acquisition of infectivity by the newly assembled virion, and thus represents a critical target for chemotherapy against AIDS. Selective inhibitors of the HIV-1 protease have been synthesized [3] and, in association with inhibitors of the reverse transcriptase, have been shown to reduce viral replication efficiently in human patients. Unfortunately, utilization of protease inhibitors can lead to the selection of virus mutants, whose protease displayed a lower affinity for drugs while maintaining cleavage rates necessary for viral replication. Mutations causing resistance were also described in cleavage sites of gag and gag-pol precursors, resulting in more efficiently cleaved substrates [4, 5] .
The protease appears highly specific in that it catalyses the cleavage of a limited number of sites in the gag and gag-pol precursors ( Figure 1A ). On the other hand, the HIV-1 protease can hydrolyse a large variety of peptides and fails to show a clear preference for particular amino acid residues at any position flanking the scissile bond. Substrates are, nevertheless, divided into two broad classes, those having a proline residue at P1h (according to the nomenclature of Schecter and Berger [6] ) and those having two hydrophobic amino acids at P1 and P1h [7] . Depending on the type of cleavage site, the protease has been described to have different preferences at the P2 and P2h positions. For cleavage sites with a Pro at P1h, the presence of Asn at the P2 position and β-branched Val or Ile at the P2h position were found to favour the hydrolysis. β-branched Val at the P2 position and Glu or Gln at P2h were preferred for the processing of bonds between two hydrophobic residues. Enzymic characterization of the HIV-1 protease has mainly been carried out with synthetic peptides and their derivatives systematically altered in their chemical structure [8] . Thus the dependence of the protease specificity on the conformational context remains largely unAbbreviations used : CA, capsid protein ; IN, integrase ; IS, insertion site ; MA, matrix protein ; p6 pol , preprotease ; RT, reverse transcriptase ; TS ; thymidylate synthase.. 1 To whom correspondence should be addressed (e-mail sonigo!cochin.inserm.fr).
described as the consequence of cumulative interactions, globally favourable, between at least six amino acids around the cleavage site. To investigate influence of local sequence, we introduced insertions of variable lengths in two exposed loops of the TS. In both environments, insertion of only two amino acids could determine specific cleavage. We then inserted libraries of dipeptides naturally cleaved by the HIV-1 protease in order to assess the limitations of established classifications of substrates in different conformational contexts.
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explored, though this aspect is critical to the understanding of the kinetically driven mechanism of the particle maturation. We wished to develop an experimental approach which allows the sequence and spatial structure of the substrate to be varied in a controlled manner. In a previous work, we have performed extensive insertional mutagenesis of the Escherichia coli thymidylate synthase (TS) gene [9] , and found several sites which could expose exogenous sequences at the surface of the protein.
By inserting natural substrate sequences, we observed the in i o cleavage of the engineered TS by HIV-1 protease.
In the present work, we analysed the influence of the structural context on substrate recognition. First, we confirmed the importance of the structural context for the proteolytic specificity by identifying a site whose processing is dependent on the TS conformation. Then, we showed that insertion of only two amino acids, Phe-Pro, within different surface loops induced specific cleavage by the HIV-1 protease. Finally, we tested the cleavage of sites varying in size, sequence or conformational context. These results revealed the limitations of the previous classification of substrates and define better the relationships between local and spatial factors affecting cleavage efficiency.
EXPERIMENTAL

Plasmids
The 1.3 kb E. coli thyA fragment PTZthyA was first subcloned from pBTAH2 [10] into the phagemid pTZ18R (Amersham Pharmacia Biotech) using HindIII sites. The Hin dIII sites were replaced by XhoI sites by site-directed mutagenesis. The 2.9 kb HIV-1 pol gene fragment pSUprtj, corresponding to the protease and reverse transcriptase domains, was subcloned from pBRT1prtj [11] into pSU19 [12] , using the EcoRI and SalI sites. The 1.5 kb HIV-1 pol fragment pSUprtk, corresponding solely to the reverse transcriptase domain, was also subcloned from pBRT3prtk [11] into pSU19 using the EcoRI and Sal I sites. pBRT1prtj and pBRT3prtk clones were provided by the (10, 8, 6 or 5) , and additional mutagenesis (for example SR indicates the modified residues at the cleaved site, by means of antisense insertion). Residues that belong to the primary structure of the wild-type E. coli TS are italicized. Val and Asn residues, which are underlined, are encoded by the HpaI restriction site introduced during the mutagenesis (as described in the Experimental section).
National Institutes of Health (AIDS Research and Reference Reagent Program).
Insertion sequences and nomenclature of E. coli thyA mutants
Mutagenesis was performed according to Kunkel et al. [13] . Annealing and extension reactions were performed on the single stranded form of the pTZthyA phagemid DNA. Oligonucleotides were chosen to introduce a unique blunt-end HpaI restriction site to facilitate subsequent insertions at site B and C ( Figure 1B ). For the 5-10 amino acid insertions, complementary oligonucleotides coding for the HIV-1 protease targets were synthesized, hybridized and cloned in both orientations (designated as sense and antisense) within the HpaI restriction site. The ligation mixtures were digested with the HpaI enzyme which no longer had a recognition sequence within the desired clones. The ligation mixtures were then used to transform competent E. coli DH5α cells. For smaller insertions, oligonucleotides coding for the mutations were annealed on the single-stranded form of the modified pTZthyA. The Val and Asn encoded by the HpaI restriction site were either conserved or deleted, according to the sequence context required. Mutants were identified by nucleotide sequencing using a commercial kit (Amersham International). The first three letters designate the site of insertion (i.e. ISC means insertion site C), the following characters designate either the sequence inserted and its length (i.e. ISC F10 means the ten amino acid in length F sequence inserted at site C) or simply the amino acids inserted ( Figure 1C ).
E. coli strains
Expression of the mutants was performed in the β-1308 : ∆-thyA : :Em derivative of the wild-type MG 1655 E. coli K12 (F − λ − ). Cells were grown on Luria-Bertani broth complemented with thymidine (100 µg\ml), ampicillin (50 µg\ml) and chloramphenicol (25 µg\ml) at 30 mC.
Antibodies and protein extracts for immunoblotting experiments
Pellets corresponding to 1.5 ml cultures of β-1308 bacteria were resuspended in 150 µl of buffer [0.5 mM 4-(2-aminoethyl)-benzenesulphonyl fluoride, 4 mM 2-mercaptoethanol and 50 mM Tris\HCl, pH 7.5], frozen in liquid nitrogen and thawed three times. Cellular debris was removed by centrifugation (30 min at 12 000 g), and soluble proteins were analysed by SDS\PAGE and Western blotting. Polyclonal antibodies against E. coli TS were prepared by injecting a rabbit with a synthetic peptide corresponding to the 24 amino acids of the C-terminus of TS. Total protein concentration was determined in the extracts by the Biuret method (BCA kit, Pierce).
Immunopurification of cleavage products and microsequencing
Soluble proteins corresponding to 500 ml of culture of transformed β-1308 bacteria were resolved by SDS\PAGE. Proteins were revealed by Coomassie Blue staining and bands containing the cleavage products, around 27 kDa and 21 kDa, were excised from the gel. The bands were incubated in 0.1 % SDS and 100 mM Tris\HCl, pH 8.0, overnight at 37 mC. Gel was removed by filtering through a 0.45 µm membrane (Millipore) and the supernatant was concentrated on centriprep-10 (Amicon). SDS and Coomassie blue were eliminated by precipitation with an excess of 10 % cetyltrimethylammonium bromide. Samples were centrifuged (30 min at 150 000 g). The supernatants were diluted in PBS and loaded on the top of a 1-ml affinity column. The affinity column was prepared by covalently coupling the purified polyclonal antibody directed against the C-terminal region of the E. coli TS to Protein A-Sepharose, using the Immunopure IgG orientation kit (Pierce). Unbound material was removed by washing with 30 ml of PBS and specific binding was disrupted by elution with 0.1 M glycine, pH 2.5. The eluate was neutralized by addition of 1 M Tris, pH 9, and concentrated on centricon-10 (Amicon). The proteins were separated by SDS\PAGE and electroblotted on to PVDF membrane. After Coomassie Blue staining, discrete protein bands were closely excised from the membrane. The N-terminal amino acid sequences of the samples was determined on a 473A sequencer (Applied Biosystem).
RESULTS
Conversion of the E. coli TS into HIV-1 protease substrate
E. coli TS was shown previously to be permissive to exogenous insertions in two exposed loops designated as B and C [9] . By introducing the preprotease (p6 pol )-protease (' PR ') junction (F), SFNF PQIT, the matrix protein (MA)-capsid protein (CA) junction (Y), SQNY PIVQ, or the reverse transcriptase (RT)-HIV-1 protease substrate specificity The in i o processing was revealed by the appearance of a cleavage product, which migrated at the predicted size of 21 kDa (Figure 2 ). The C-terminal fragment of the TS ISC F10 mutant was purified using an immuno-affinity column, and its amino acid sequencing confirmed that the cleavage occurred at the Phe-Pro bond of the target sequence SFNF PQIT.
Cleavage of two altered substrates
Two cleavage sites, altered at P1 and P1h, were introduced at site C. The selected mutations, Ser-Arg in place of Phe-Pro in the p6 pol -protease sequence context SFNSRPQIT [14] and Ser-Pro in place of Tyr-Pro in the MA-CA sequence context SQNSPIVQ [15] , have been described previously as blocking proteolysis, even in the presence of an excess of purified HIV-1 protease. In particular, substitution of Ser for Tyr in the MA-CA junction was shown to inhibit cleavage of the synthetic peptide SQNSPIVQ, as well as proteolytic maturation of the gag precursor [15] . By contrast, in the structural context of the TS, the two altered target sequences were cleaved, albeit at a very low 
Figure 4 Influence of the length of the inserted target sequence on its recognition by the HIV-1 protease
(A) Representation of the proteolytic degradation of the engineered TS and its visualization by immunoblotting using antibodies directed against the C-terminus of TS. The cryptic fragment can be detected by immunoblotting only if cleavage at site C is partial. (B and C) Analysis by immunoblotting using TS-specific antibodies. β-1308 cells were transformed by two constructs, a pTZThyA mutant and a pSUprt plasmid expressing either an active (j) or a defective (k) HIV-1 protease protein. The HIV-1 protease could cleave insertions of decreasing length from ten to five residues in the structural context of the wild-type TS (B), while the protease was not able to cleave the six and five amino acid long targets in the structural context of the F42W TS mutant (C). Abbreviations : C-term, C-terminus ; N-term, N-terminus.
efficiency, by the HIV-1 protease, as revealed by the presence of cleavage products (Figure 2 ). In this regard, the surface loop C certainly provided a suitable conformation for hydrolysis of target sequences and therefore, a sensitive method for revealing cleavage events. Insertion of unrelated peptide did not result in cleavage, as shown with the inserted sequence DAIQEQHFAD.
Identification of a conformation-dependent cleavage site
Wild-type TS is resistant to the action of the viral protease ( Figure 3 ) and only one cleavage product at 21 kDa was detected
Figure 5 In vivo cleavage of dipeptides inserted in sites B or C
Analysis by immunoblotting using TS-specific antibodies. β-1308 cells were transformed with two constructs, a pTZThyA mutant and a pSUprt plasmid expressing either an active (j) or a defective (k) HIV-1 protease protein.
with TS mutants exposing HIV-1 protease substrates (Figure 2) . However, after insertion of an unrelated peptide at site C, another cleavage product migrated at 27 kDa ( Figure 2 ). This fragment was purified by affinity chromatography and its Nterminus was sequenced, yielding the amino acid sequence XXVTTKR, localizing the cleavage site to Phe%# ( Figure 1B) . The substrate sequence QDGF PLVT was consistent with the known property of the HIV-1 protease to cleave the Phe-Pro bond. We observed that insertion of as few as two amino acids, 
, Cleaved bond ; *, from Poorman et al. [21] ; †, hydrolysed by the HIV-2 protease ; nd, not determined ; l , uncleaved bond.
Val-Asn, at site C was sufficient to render this cleavage site, designated as cryptic, susceptible to the HIV-1 protease ( Figure  3 ). Substitution of Phe%# by Trp, another aromatic residue that has never been observed in the scissile bond of proteolytic sites, blocked the processing of the cryptic site ( Figure 3) .
Determination of the minimal length of insertion that could induce cleavage
Studies with synthetic peptides showed that the 6-8 residues occupying P4-P4h were necessary to give specific and efficient cleavage [8, 16, 17] . On the other hand, some results support the strong interaction of chemically modified tetra-and even tripeptides with the active site of the HIV-1 protease [3] . We tested several insertions of decreasing length from ten to five residues to determine the critical core which was sufficient for cleavage in the heterologous context of the engineered E. coli TS ( Figure 4B ). At five amino acids, an efficient cleavage occurred, although with a reduced efficiency for the smaller insertions, as revealed by visualization of the cryptic fragment. Indeed, only TS C-terminal fragments can be detected with our anti-peptide antibody. Therefore, as site C is located 45 amino acids downstream of the cryptic site, the cryptic fragment could be revealed only if the cleavage at site C occurred with a reduced efficiency, as happened with insertion of six and five residues ( Figure 4) . We engineered the same constructions in the F42W TS mutant in which the cryptic cleavage site was blocked. HIV-1 protease was still able to cleave the ten and eight amino acid long targets ( Figure 4C ), while the smaller insertions of six and five amino acids were no longer processed. Considering that the target sequences were strictly identical in the wild-type TS and F42W mutant, conformation of the inserted sites should be responsible for the observed dissimilarities in processing efficiency. These differences were observed under physiological conditions (i.e. at neutral pH) and without previous denaturation steps such as treatment with SDS [18] or acidification [19] .
Dipeptide insertions induced specific cleavage in two different structural contexts
We pursued the investigation of the minimal insertion that allowed proteolytic processing of the TS. We introduced only two amino acids, Phe-Pro, at site B, ENNF PVTI, and at site C, DENF PGDL. The presence of the flanking Asn at P2 in both sites B and C and the β-branched Val at P2h in site B, while fortuitous, is known to define an appropriate sequence context HIV-1 protease substrate specificity for the cleavage of peptide bonds containing a Pro at the P1h position.
The engineered surface loops resulted in specific cleavage at the two sites with relatively high efficiency, especially at site B ( Figure 5A) . Microsequencing of the C-terminal fragment confirmed that cleavage of the TS ISB FP actually occurred between the inserted Phe and Pro residues. Cleavage at site C was less efficient as revealed by the presence of the cryptic fragment in addition to the C fragment (see Figure 4) . Proteolysis was more efficient following insertion of the dipeptide Phe Pro at both sites B and C (ISBC FP), than after insertion of Phe Pro in only one of the two sites ( Figure 5A ).
Finally, we inserted dipeptides cleaved in gag and gag-pol precursors or in non-viral substrates (Table 1) . In order to study the context dependence of HIV-1 protease specificity, we introduced Val and Asn at P2 and P2h respectively in site C, while conserving the naturally occurring Asn and Val in site B. All combinations containing a Leu at the P1 position, LF, LY and LA, were hydrolysed poorly or not at all in the context of site B (Figures 5B and 5C ). In contrast, LF was cleaved efficiently in site C ( Figure 5A ). Otherwise, we observed the cleavage of all dipeptides tested in the heterologous context of the TS loops B and C (Table 1 and Figure 5 ).
DISCUSSION
The exploration of substrate specificity of HIV-1 protease has principally been carried out using synthetic peptides. According to available results, it remains difficult to establish consensus sequences or rules defining protease specificity. Moreover, the use of free peptides does not address the role of global structures and interactions. The experimental system presented here allowed us to dissociate the influence of the target sequence (controlled by mutagenesis) and the conformational context (controlled by the TS structure at sites B and C).
In a previous study [9] , we reported that the HIV-1 protease is able to recognize and process target sequences inserted into different surface loops of E. coli TS, whose structure is well characterized. Here, we confirmed that the conformational context exhibited by the TS is suitable to study the cleavage specificity of the HIV-1 protease. This system is sensitive enough to detect low cleavage efficiency as shown with modified targets described previously to be resistant to the retroviral protease. The TS system allowed us to assess the influence of the conformation upon the protease substrate recognition. We identified a cryptic site whose cleavage by the HIV-1 protease was dependent on the protein folding. The processing of the cryptic site, located 45 amino acids upstream of loop C ( Figure  1B) , was detected only in TS mutants destabilized by peptide insertion. In fact, proteases are known to degrade some proteins extensively only after these proteins loose their structural organization. Thus, albeit conservative, insertion mutagenesis of only two amino acids may be destabilizing enough to allow sufficient interaction between the enzyme and its potential substrate. Insertion in site C may have produced a new stable conformation of TS combining both TS activity and exposure of the previously hidden cryptic site. Alternatively, insertion at site C may have produced a dynamic instability resulting in structural diversity in the population of TS molecules. At any given time, cleaved molecules might be different from active molecules. The cleaved TS might be recruited from the most destabilized and inactive fraction of the enzymic population. This second interpretation does not require the existence of a TS conformation which is both active and different from the wild-type.
The presence of two amino acids, Phe-Pro, at the cryptic site or at the surface loops B and C was sufficient to induce a specific cleavage by the HIV-1 protease. It is noteworthy that the three loops cleaved specifically by the HIV-1 protease shared only two characteristics : the Phe-Pro dipeptide and their exposure at the protein surface [20] . It is unlikely that these three sites have additional structural features in common. Thus we may ask whether a neutral or even an unfavourable sequence context (i.e. in the absence of P4, P3, P3h and P4h residues known to stabilize the protease-substrate complex) could be compensated by an appropriate conformation such as those provided by the TS surface loops. Subsequently, we verified that other dipeptides, cleaved in the natural sequence context of the gag and gag-pol precursors, were also processed in the heterologous context of the TS. In our system, the class I sequence context, with Pro at P1h, was displayed by loop B of the TS while the sequence of loop C favoured the processing of sites belonging to class II, between two hydrophobic amino acids. It appeared that substrates from class II did not exhibit a particular preference for a given sequence context. Most of the tested combinations of two hydrophobic amino acids were cleaved in loops B and C.
The classification into two types of substrates, mainly established by studies on short peptides, does not allow predictions of cleavage in a protein context. The limitations of such classification [14] are certainly due to the variable exposure of cleavable bonds in a larger protein. In this context, the apparent cleavage specificity observed in viral proteins might result from the combination of the dynamics of exposure and the kinetics of cleavage. A compact globular protein remains unprocessed, even at favourable sequences, as we observed for the TS cryptic site. A short exposure would allow cleavages occurring with rapid kinetics ; such may be the case for the conformation-dependent cleavage that we observed at a Phe-Pro bond, in an enzymically active, and thus relatively compact, TS mutant. A long exposure would allow more cleavage to occur, even at less favourable dipeptides. Very long exposure, corresponding to denaturation of the target, would allow cleavage at many sites, leading to complete degradation of the target protein. These considerations can be applied for the analysis of mutants emerging during exposure to protease inhibitors. Until now, mutations of resistance were identified exclusively in the protease gene or in sequences encoding cleavage sites. As shown in this report, some distant mutations can alter the presentation of the maturation sites and consequently could result in an improved apparent affinity of the HIV-1 protease for its substrates. Such resistance against drugs for protease binding could be associated with a relatively weak loss of viral fitness [22] and are, consequently, of critical interest.
